1Y Annualised Return
▲55.34%
3Y Annualised Return
▲28.95%
5Y Annualised Return
▲25.21%
10Y Annualised Return
▲0.44%
Concord Drugs Stock Performance
|
|
|
Concord Drugs Company background
Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Concord Drugs Financial Highlights
For the full year FY2025–2026, revenue
reached ₹45.26 crore and profit touched at
₹0.34 crore.
Concord Drugs Share Price Today
As of 2 Nov 2025, Concord Drugs share price is ₹69. The stock opened at ₹64.7 and had closed at ₹66.8 the previous day. During today’s trading session, Concord Drugs share price moved between ₹64.74 and ₹70.00, with an average price for the day of ₹67.37. Over the last 52 weeks, the stock has recorded a low of ₹26.10 and a high of ₹71.50. In terms of performance, Concord Drugs share price has increased by 130.5% over the past six months and has increased by 55.34% over the last year.
Concord Drugs SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹6,02,988 in 5 years with a gain of ₹3,02,988 (+101.00%)
Concord Drugs Fundamental
Market Cap (in crs)
69.04
Face Value
10
Turnover (in lacs)
3.00
Key Metrics
Qtr Change %
New 52W High in past week
23.3
Dividend yield 1yr %
0
Concord Drugs Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Concord Drugs Quarterly Revenue
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
13.61 Cr | 10.39 Cr | 10.8 Cr | 12.36 Cr | 11.69 Cr |
Concord Drugs Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|
45.26 Cr | 44.93 Cr | 52.09 Cr |
Concord Drugs Quarterly Net Profit/Loss
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
0.12 Cr | 0.04 Cr | 0.23 Cr | 0.04 Cr | 0.03 Cr |
Concord Drugs Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|
0.34 Cr | 0.47 Cr | 0.99 Cr |
Concord Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
69.04
Current Price
5Day EMA
67.50
10Day EMA
66.90
12Day EMA
66.80
20Day EMA
66.50
26Day EMA
66.20
50Day EMA
63.90
100Day EMA
57.80
200Day EMA
50.20
5Day SMA
67.70
10Day SMA
66.10
20Day SMA
66.60
30Day SMA
66.60
50Day SMA
64.90
100Day SMA
57.00
150Day SMA
48.40
200Day SMA
44.90
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 3845 Rs | 4352 Rs |
Week Rs | 4940 Rs | 6004 Rs |
Month Rs | 4455 Rs | 4721 Rs |
Resistance & Support
67.93
Pivot
Resistance
First Resistance
71.11
Second Resistance
73.19
Third Resistance
76.37
Support
First Support
65.85
Second support
62.67
Third Support
60.59
Relative Strength Index
58.54
Money Flow Index
62.03
MACD
0.59
MACD Signal
0.45
Average True Range
3.54
Average Directional Index
16.19
Rate of Change (21)
3.51
Rate of Change (125)
130.52
Concord Drugs Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121.85 | 71.90 | 119 | 230 | 125.15 | -6.59% | -6.27% | -14.34% | -21.11% | -12.50% | 0.00% | 12.87 | 41.48 | 1.28 | |
0.55 | 67.98 | 0.48 | 1.44 | 0.57 | -19.12% | 10.00% | -31.25% | -21.43% | -14.06% | 0.00% | 2.50 | 41.48 | 0.66 | |
87.19 | 65.66 | 78.91 | 133.9 | 85.88 | 0.61% | 2.43% | -5.45% | -29.06% | 27.01% | 0.00% | 17.33 | 41.48 | 1.51 | |
39.00 | 70.72 | 35.5 | 97.45 | 39.10 | -11.36% | -9.30% | -32.53% | 0.00% | 0.00% | 0.00% | 16.74 | 41.48 | 1.27 | |
59.90 | 66.58 | 53.8 | 82.95 | 57.45 | 3.54% | 1.53% | 0.00% | 0.00% | 0.00% | 0.00% | 9.80 | 41.48 | 1.48 | |
83.10 | 70.74 | 80.1 | 126 | 83.05 | -6.52% | -15.46% | 0.00% | 0.00% | 0.00% | 0.00% | 18.55 | 41.48 | 1.83 |
Concord Drugs Share Price FAQs
How to buy Concord Drugs shares?
You can easily buy Concord Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Concord Drugs ?
The 52-week high and low of Concord Drugs share price is ₹71.5 and ₹26.1 as of 31/10/2025.
Please be aware that Concord Drugs stock prices are subject to continuous fluctuations due to various factors.
Invest in Concord Drugs